Come up with a name for your new list and we'll add to it:
NeoPhore raised a round of funding on November 15, 2017. Investors include
Sixth Element Capital.
NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system.…